Abstract: Provided herein is a method of treating, preventing, or managing osteolysis in a subject, comprising administering to the subject a therapeutically effective amount of vitamin C, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, in combination with vitamin K, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, or hydrate thereof.

Abstract: The present invention generally relates to methods for reducing the pH of aqueous mixtures with the advantage of preventing formation of deposits and scales on internal surfaces in contact with the aqueous systems. These methods also that the advantages that they reduce pH with less corrosion or metal loss of the internal surface as compared with a conventional strong acid used to reduce the pH in such systems. The methods use an acid composition comprising a salt of a nitrogen base having a fluoro inorganic anion.

Abstract: The present invention generally relates to methods for increasing recovery of crude oil from a subterranean hydrocarbon-containing formation and for removing or inhibiting deposits in a well, the methods comprising contacting an acid composition that comprises a salt of a nitrogen base having a fluoro inorganic anion with the well or the formation.

Abstract: Provided herein is a pharmaceutical composition comprising vitamin C and chromium-free vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Also provided herein is a chromium-free pharmaceutical composition comprising vitamin C and vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Further provided herein is a method of treating, preventing, or managing an NF?B-mediated condition, disorder, or disease, comprising administering to the subject a therapeutically effective amount of vitamin C and chromium-free vitamin K. Provided herein are methods for treating, preventing, or ameliorating one or more symptoms of a polycystic disease in a subject, comprising administering to the subject a therapeutically effective amount of vitamins C and K.

Abstract: The present invention generally relates to methods for removing silica or silicate deposits comprising contacting a cleaning composition with a surface in contact with a liquid containing silica or silicates, wherein the cleaning composition comprises a salt of a nitrogen base having a fluoro inorganic anion. In particular, these methods for removing silica or silicate deposits can be used in steam generators, evaporators, heat exchangers, and the like that are used in produced water plant unit operations.

Abstract: Provided herein is a pharmaceutical composition comprising vitamin C and chromium-free vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Also provided herein is a chromium-free pharmaceutical composition comprising vitamin C and vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Further provided herein is a method of treating, preventing, or managing an NF?B-mediated condition, disorder, or disease, comprising administering to the subject a therapeutically effective amount of vitamin C and chromium-free vitamin K.

Abstract: The present invention generally relates to methods for removing silica or silicate deposits comprising contacting a cleaning composition with a surface in contact with a liquid containing silica or silicates, wherein the cleaning composition comprises a salt of a nitrogen base having a fluoro inorganic anion. In particular, these methods for removing silica or silicate deposits can be used in steam generators, evaporators, heat exchangers, and the like that are used in produced water plant unit operations.

Abstract: Composites such as self-supporting rigid composites that include aerogel have low thermal conductivity and attractive mechanical properties. Methods for preparing such composites include, for example, combining an aerogel-containing material with a binder to form a slurry and allowing the slurry to harden. At least part of the hardening process in conducted under compression.

Abstract: Provided herein is a method of promoting wound healing in a subject, comprising administering to the subject vitamin C, vitamin K, a polyphenol, or a combination thereof. Also provided herein is a method of treating a wound in a subject, comprising administering to the subject vitamin C, vitamin K, a polyphenol, or a combination thereof.

Abstract: Provided herein is a method of treating, preventing, or managing osteolysis in a subject, comprising administering to the subject a therapeutically effective amount of vitamin C, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, in combination with vitamin K, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, or hydrate thereof.

Abstract: Provided herein are methods for treating, preventing, or ameliorating one or more symptoms of a polycystic disease in a subject, comprising administering to the subject a therapeutically effective amount of vitamins C and K.

Abstract: Provided herein is a method of treating, preventing, or managing osteolysis in a subject, comprising administering to the subject a therapeutically effective amount of vitamin C, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, in combination with vitamin K, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, or hydrate thereof.

Abstract: Methods and apparatus for cataloging and recognizing gestures are disclosed. A gesture may be detected using sample motion data. An energy value and baseline value may be computed. The baseline value may be updated if the energy value is below a calm energy threshold. The sample motion data may be adjusted based on the updated baseline value. A local variance may be calculated over a number of samples. Sample motion data values may be recorded if the local variance exceeds a threshold. Sample motion data recording may stop if a local variance scalar value falls below a drop threshold. Input Gestures may be recognized by computing a total variance for sample values in an Input Gesture; calculating a figure of merit using sample values from the Input Gesture and one or more Catalog Gestures; and determining whether the Input Gesture matches a Catalog Gesture from the figure of merit.

Abstract: A computer-based score tracking system and method that may be used in equestrian judging. The system includes a judge portal, an office portal, an in gate portal and a spectator portal for accessing a computer based server. Mobile computing devices interact with the computer based server to provide real-time updates to scoring and judge comments to spectators. The system allows judges to use customized hand written symbols, letters, and numbers to identify a particular result, while maintaining an organized and numerical ranking system based upon aggregated totals. Additionally, the system allows for tracking of participants to assist in providing accurate judging and location of participants. System is adapted to receive a finalized score card and send final results to office personnel.

Abstract: A total variance may be computed for sample values in an input gesture including a plurality of sample values of sample motion data from one or more sensors associated with a control device. The motion data may be related to movement of a control device. A figure of merit may be calculated using the sample values in the gesture, the total variance for the sample values in the input gesture, and sample values in one or more catalog gestures. The figure of merit measures how well the samples in the input gesture match samples in the catalog gesture. Whether an input gesture matches one of the one or more catalog gesture may be determined based on the figure of merit. A state of the system may be changed if it is determined that the input gesture matches the one of the one or more catalog gestures.

Abstract: Provided herein are methods for treating, preventing, or ameliorating one or more symptoms of a polycystic disease in a subject, comprising administering to the subject a therapeutically effective amount of vitamins C and K.

Abstract: Compositions comprising combinations of magnesium ascorbate (magnesium Vitamin C of “MgVC2”) and Vitamin K3 or (VK3) or a quinone and semiquinone analogue of VK3, are used in methods for killing or inhibiting the growth of tumor or cancer cells or preneoplastic cells in a subject, or for treating cancer in a subject in need of such treatment.

Abstract: Provided herein is a pharmaceutical composition comprising vitamin C and chromium-free vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Also provided herein is a chromium-free pharmaceutical composition comprising vitamin C and vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Further provided herein is a method of treating, preventing, or managing an NFKB-mediated condition, disorder, or disease, comprising administering to the subject a therapeutically effective amount of vitamin C and chromium-free vitamin K.

Abstract: An initiation device for initiation of an explosives charge, which comprises: a transceiver for receipt of wireless command signals; a control circuit for processing of wireless command signals received by the transceiver; and a light source that is suitable for initiation of the explosives charge and that is activated by the control circuit.

Abstract: A computer system can determine a user identification key associated with a user of a component device in response to connection of the component device to the computer system. The system automatically accesses an account associated with the user by sending the user identification key to a network associated with the computer system. The system receives data associated with the user account from the network and runs a computer application in accordance with the received data. The application receives input from the component device corresponding to user manipulation of the component device. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.